Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• Sarcoma presents challenges in therapeutic target discovery due to rarity and heterogeneity.
• Immune cell infiltration within the tumor microenvironment (TME) is a promising avenue for cancer treatment.
• Competing endogenous RNA (ceRNA) networks are crucial in tumor development, but their role in sarcoma's TME is not well understood.

Purpose of the Study:

• To investigate the role of the ceRNA regulatory network in the tumor microenvironment (TME) of sarcoma.
• To construct an immune cell infiltration-related ceRNA network for sarcoma.
• To develop a prognostic risk score model for sarcoma patients based on ceRNA network components.

Main Methods:

• Utilized gene expression data and clinical information from The Cancer Genome Atlas (TCGA) sarcoma datasets.
• Constructed a ceRNA network incorporating lncRNAs, miRNAs, and mRNAs associated with immune infiltration.
• Developed a risk score model using key genes (IRF1, MFNG) and microRNAs (hsa-miR-940, hsa-miR-378a-5p).

Main Results:

• Successfully constructed an immune infiltration-related ceRNA network comprising 14 lncRNAs, 13 miRNAs, and 23 mRNAs.
• Identified IRF1, MFNG, hsa-miR-940, and hsa-miR-378a-5p as significant components of the network.
• The developed risk score model demonstrated promising performance in predicting sarcoma patient prognosis.

Conclusions:

• The constructed ceRNA network provides insights into the molecular mechanisms of sarcoma development within the TME.
• The immune infiltration-related risk score model offers a potential tool for predicting sarcoma patient outcomes.
• This study highlights the significance of ceRNA networks and immune infiltration in sarcoma, paving the way for novel therapeutic strategies.